The Apothecary Shops Receives Exclusive Distribution Rights for Mitosol®
PHOENIX, Feb. 17, 2012 /PRNewswire-iReach/ — Apothecary Shop Wholesale, Inc., an affiliate of The Apothecary Shops Specialty Pharmacies, has received exclusive distribution rights from Mobius Therapeutics, LLC for its new drug Mitosol® (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use.
The Mitosol® Kit for Ophthalmic Use provides ophthalmic surgeons a new means of delivering a precise dose of its active ingredient, mitomycin-c, for use in glaucoma surgical procedures, without requiring a change to existing surgical technique. Last week, Mitosol® was approved by the Food and Drug Administration for use in as an antimetabolite indicated as an adjunct to ab externo glaucoma surgery. ( See full prescribing information at )
“The approval of Mitosol® for use in glaucoma surgery represents the culmination of years of work on the part of Mobius Therapeutics(TM),” said Ed Timm, President of Mobius Therapeutics(TM). “It will provide surgeons, hospitals and patients with enhanced convenience, safety and consistency in the surgical treatment of glaucoma.”
Since opening its first location in Arizona in 1996, The Apothecary Shops has focused on specific disease states, including ophthalmology, and has vast experience in providing medications for patients with eye-related illnesses and diseases. To best serve their patients, The Apothecary Shops has a dedicated ophthalmology sales and pharmacist team, VAWD Accreditation, and a wholesale division for office ordering.
“The Apothecary Shops is the ideal partner to distribute Mitosol®,” said Ed Timm, President and CEO of Mobius Therapeutics. “Their expertise and deep understanding of ophthalmology combined with exceptional customer service levels gives us great confidence in their ability to provide the market an uninterrupted source of supply and a superior customer experience.”
“We’re proud to be selected by Mobius Therapeutics as the exclusive distribution partner for this very important new drug, and better serve our customers”, said Sheri Garver, Apothecary Shop Wholesale Director.
Glaucoma is the second-leading cause of blindness in the United States; it is incurable and loss of vision is irreversible. Once diagnosed, medication and/or surgery may halt further loss of vision. Although often thought of as a disease that affects the elderly, glaucoma strikes people of all ages. The best way to protect your sight from glaucoma is to get tested, and if diagnosed, begin treatment immediately. (Source: Glaucoma Resource Foundation website, February, 2012)
About The Apothecary Shop Wholesale, Inc.
Apothecary Shop Wholesale is a VAWD accredited wholesaler affiliated with a national specialty pharmacy, The Apothecary Shops, which has provided individualized care and support to patients since 1996. Specialties include ophthalmology, oncology, infectious diseases, including HIV/AIDS and hepatitis, fertility, pain management, women’s health, and transplant-related medicines. The Apothecary Shops’ clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The Apothecary Shops offer a nationwide specialty national distribution service to complement 16 physical locations. For more information, visit: www.theapothecaryshop.com.
About Mobius Therapeutics, LLC
Mobius Therapeutics, LLC is a St. Louis-based commercial stage venture focused on ophthalmic surgery solutions. Its first product, Mitosol®, is a system for delivering antifibrotic agents in glaucoma, refractive, and corneal surgery. The glaucoma indication is in active commercialization; the refractive and corneal indications are awaiting approval by the Food and Drug Administration. For more information, visit: www.mobiustherapeutics.com.
Jackie Wright Rainmaker Integrated, 480-361-4348, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Apothecary Shop Wholesale, Inc.